Treatments for Advanced or Recurrent Endometrial Cancer: Beyond Chemotherapy

home / insights / treatments-for-advanced-or-recurrent-endometrial-cancer-beyond-chemotherapy

Experts discuss the evolving treatment landscape in advanced or recurrent endometrial cancer. They review the latest updates in clinical research, highlighting non-chemotherapy approaches and their impact on treatment selection.

Experts on endometrial cancer

EP. 1: An Overview of Endometrial Cancer

Bradley J. Monk, MD, FACS, FACOG;Christian Marth, MD, PhD
June 20th 2023

Christian Marth, MD, PhD, discusses the prevalence of endometrial cancer, as well as the steps that lead to diagnosis.

Experts on endometrial cancer

EP. 2: Chemotherapy Options for Endometrial Cancer

Bradley J. Monk, MD, FACS, FACOG;Christian Marth, MD, PhD
June 20th 2023

Bradley J. Monk, MD, FACS, FACOG, reviews the available chemotherapy options for treating advanced and recurrent endometrial cancer, as well as compares notes with Christian Marth, MD, PhD, on his clinical experience.

Experts on endometrial cancer

EP. 3: Clinical Trials of Immunotherapies in Endometrial Cancer

Bradley J. Monk, MD, FACS, FACOG;Christian Marth, MD, PhD
June 27th 2023

Christian Marth, MD, PhD, and Bradley J. Monk, MD, FACS, FACOG, discuss data from the NRG GY018 and RUBY trials regarding the use of immunotherapies for the treatment of endometrial cancer.

Experts on endometrial cancer

EP. 4: Future Outlook for Endometrial Cancer Treatment

Bradley J. Monk, MD, FACS, FACOG;Christian Marth, MD, PhD
June 27th 2023

Experts discuss the possibility to avoid use of chemotherapy by using immunotherapy.

Experts on endometrial cancer

EP. 5: Treatment Strategies in Non-Responders to Chemotherapy

Bradley J. Monk, MD, FACS, FACOG;Christian Marth, MD, PhD
July 4th 2023

Bradley J. Monk, MD, FACS, FACOG, and Christian Marth, MD, PhD, share treatment approaches to patients with endometrial cancer with a low response rate to chemotherapy, highlighting a biomarker-based approach.

Experts on endometrial cancer

EP. 6: Adverse Events Associated With Immunotherapy in the Treatment of Endometrial Cancer

Bradley J. Monk, MD, FACS, FACOG;Christian Marth, MD, PhD
July 4th 2023

Christian Marth, MD, PhD, reviews the adverse effects of pembrolizumab and lenvatinib in the treatment of endometrial cancer, as well as the patient experience with these treatments.